Lorraine Elizabeth Clarke

Title: Innovative Contributions of Lorraine Elizabeth Clarke

Introduction

Lorraine Elizabeth Clarke is an accomplished inventor based in Cumnor, GB. With a remarkable portfolio that includes two patents, she has made significant contributions to the field of immunology, particularly concerning the fight against coccidiosis in poultry. Her work embodies a blend of scientific expertise and innovative thinking, pushing the boundaries of current research.

Latest Patents

Clarke’s latest inventions include a patent for "Eimeria tenella polypeptide and vaccine containing same." This invention is centered around a protein that exhibits immunological properties specific to Eimeria tenella, a parasite responsible for coccidiosis in chickens. It has been found to react with a monoclonal antibody known as E. TEN 11P-2, which is raised against E. tenella sporozoites. Additionally, her patent covers polypeptide fragments of this protein that can be utilized for immunization against E. tenella. These proteins and polypeptides can be produced through various methods, including isolation from E. tenella, chemical synthesis, or recombinant DNA techniques using the described polynucleotides or related sequences. The second patent, titled "Coccidiosis vaccine," shares a similar focus, emphasizing the importance of these findings in developing effective vaccination strategies against the disease.

Career Highlights

Lorraine Elizabeth Clarke currently works for AkzoNobel N.V., a company renowned for its advancements in paints and coatings, as well as specialty chemicals. Her career has evolved through rigorous research and practical applications in immunology, establishing her as a prominent figure in her field.

Collaborations

Throughout her career, Lorraine has collaborated with notable colleagues, including Fiona Margaret Tomley and Rein Dijkema. These collaborations have facilitated valuable knowledge exchange and innovation in addressing the challenges posed by diseases in poultry, particularly coccidiosis.

Conclusion

Lorraine Elizabeth Clarke’s innovative contributions and dedication to her work have significantly impacted the research landscape in immunology. With her patents focusing on key proteins and vaccines, she continues to pave the way for advancements in the prevention and treatment of coccidiosis, showcasing the importance of scientific innovation in agriculture and animal health.